The Effect of Dopaminergic Medication on Straight Walking and Turning in Parkinson’s Disease Patients during Single and Dual Tasking
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Tübingen, Universität Tübingen, Dissertation, 2020
- Schlagwort
-
Patients
Walking
Parkinson-Krankheit
- Ereignis
-
Veröffentlichung
- (wo)
-
Tübingen
- (wer)
-
Universitätsbibliothek Tübingen
- (wann)
-
2020
- Urheber
- URN
-
urn:nbn:de:bsz:21-dspace-1093131
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Elshehabi, Morad
- Universitätsbibliothek Tübingen
Entstanden
- 2020
Ähnliche Objekte (12)
Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
Dopaminergic neuron metabolism: relevance for understanding Parkinson’s disease
Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?
Impact of sub-thalamic nucleus deep brain stimulation on dual tasking gait in Parkinson’s disease
Gangbildveränderungen im Rahmen von Dual-Tasking bei Parkinson-Patienten und Gesunden
Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease
Motivational modulation of bradykinesia in Parkinson’s disease off and on dopaminergic medication
Clinical characteristics of fatigued Parkinson’s patients and the response to dopaminergic treatment
Loss of Drosha underlies dopaminergic neuron toxicity in models of Parkinson’s disease
Gastrodin protects dopaminergic neurons via insulin-like pathway in a Parkinson’s disease model
Unraveling connectivity changes due to dopaminergic therapy in chronically treated Parkinson’s disease patients
Açai Berry Mitigates Parkinson’s Disease Progression Showing Dopaminergic Neuroprotection via Nrf2-HO1 Pathways
Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
Dopaminergic neuron metabolism: relevance for understanding Parkinson’s disease
Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?
Impact of sub-thalamic nucleus deep brain stimulation on dual tasking gait in Parkinson’s disease
Gangbildveränderungen im Rahmen von Dual-Tasking bei Parkinson-Patienten und Gesunden
Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease
Motivational modulation of bradykinesia in Parkinson’s disease off and on dopaminergic medication
Clinical characteristics of fatigued Parkinson’s patients and the response to dopaminergic treatment
Loss of Drosha underlies dopaminergic neuron toxicity in models of Parkinson’s disease
Gastrodin protects dopaminergic neurons via insulin-like pathway in a Parkinson’s disease model
Unraveling connectivity changes due to dopaminergic therapy in chronically treated Parkinson’s disease patients
Açai Berry Mitigates Parkinson’s Disease Progression Showing Dopaminergic Neuroprotection via Nrf2-HO1 Pathways
Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
Dopaminergic neuron metabolism: relevance for understanding Parkinson’s disease
Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?
Impact of sub-thalamic nucleus deep brain stimulation on dual tasking gait in Parkinson’s disease
Gangbildveränderungen im Rahmen von Dual-Tasking bei Parkinson-Patienten und Gesunden
Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease
Motivational modulation of bradykinesia in Parkinson’s disease off and on dopaminergic medication
Clinical characteristics of fatigued Parkinson’s patients and the response to dopaminergic treatment
Loss of Drosha underlies dopaminergic neuron toxicity in models of Parkinson’s disease
Gastrodin protects dopaminergic neurons via insulin-like pathway in a Parkinson’s disease model
Unraveling connectivity changes due to dopaminergic therapy in chronically treated Parkinson’s disease patients